Study	Reason for exclusion
ADAPT	Does not measure relapse and is not specified as a relapse prevention study
Birmaher 1998	10‐week acute phase treatment only involving a treatment resistant population
Birmaher 2000	Acute phase treatment only
Eli 1986	Acute phase treatment only
Eli 1995	Acute phase treatment only
Emslie 2009	Acute phase treatment only
Franchini 2006	Not a RCT
GlaxoSmithKline 1997	Acute phase treatment only in adolescent population
GlaxoSmithKline 2001	Acute phase treatment only in adolescent population
TADS(acute phase)	Acute phase treatment only in adolescent population

RCT: randomised controlled trial